Imperva (IMPV) Tops Q2 EPS by 13c, Q3 & FY Guidance Beats

Imperva (NYSE: IMPV) reported Q2 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $53.5 million versus the consensus estimate of $48.55 million.

Imperva sees Q3 2015 EPS of $0.05-$0.06, versus the consensus of ($0.16). Imperva sees Q3 2015 revenue of $55-57 million, versus the consensus of $52.40 million.

Imperva sees FY2015 EPS of ($0.46)-($0.44), versus the consensus of ($0.69). Imperva sees FY2015 revenue of $215-217 million, versus the consensus of $206.88 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c